Everest Bank Ltd Pharmaceutical Import Profile — Nepal (DGFT 2022–2026)

Name: Everest Bank Ltd Pharmaceutical Import Records from India — 2 Products, $526.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Everest Bank Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $526.9K Trade | TransData Nexus

Everest Bank Ltd

Pharmaceutical Importer · Nepal · Ayurvedic & Herbal Products Focus · $526.9K Total Trade · DGFT Verified

Everest Bank Ltd is a pharmaceutical importer based in Nepal with a total trade value of $526.9K across 2 products in 2 therapeutic categories. Based on 85 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Everest Bank Ltd sources from 7 verified Indian suppliers, with Emami Limited accounting for 60.1% of imports.

Everest Bank Ltd — Import Portfolio & Supplier Network

Everest Bank Ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Everest Bank Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Emami Limited	$1.9M	280	60.1%
Zydus Wellness Products Limited	$432.7K	43	13.7%
Natco Pharma Limited	$272.1K	78

What Formulations Does Everest Bank Ltd Import?

Formulation	Value	Ships
Emami kesh king scalp and hair	$281.2K	77
Zandu balm 8 ML	$179.4K	14
Boroplus healthy skin ayurvedic	$131.3K	23
Zandu balm ultra power 8 ML	$110.1K	11
Nycil cool herbal 150g+50g exp (60)	$101.0K	4
Navratna ayurvedic oil cool 200 ML	$90.7K	13
Navratna ayurvedic oil cool 2.7 ML	$87.4K	9
Ultracet tablet 15's batch	$71.9K	4
Navratna ayurvedic oil cool 2 7 ML	$71.7K	3
Nycil cool herbal 150g 50g exp	$64.9K	4
Boroplus healthy skin ayurvedic antiseptic cream 40 ML	$52.8K	2
Zandu balm 8ML	$51.4K	2
Zandu chawanprash-avleha 450	$50.0K	5
Nycil cool classic 150g+50g exp (60)	$47.9K	4
Navratna ayurvedic oil cool 300 ML	$44.6K	9

Everest Bank Ltd imports 207 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ayurvedic	Ayurvedic & Herbal Products	$507.5K	82	2.2%	12
2	Carfilzomib	Advanced Oncology	$19.5K	3	1.6%	3

Everest Bank Ltd imports 2 pharmaceutical products across 2 categories into Nepal totaling $526.9K.

Everest Bank Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Everest Bank Ltd, headquartered in Kathmandu, Nepal, is a prominent financial institution primarily engaged in banking services. While its core operations focus on financial services, the bank has also been involved in the importation of pharmaceutical products, particularly finished formulations such as tablets, capsules, syrups, and injections. This diversification into pharmaceutical imports underscores the bank's strategic interest in the healthcare sector, aiming to enhance the availability of essential medicines within Nepal.

2Distribution Network

Specific details regarding Everest Bank Ltd's warehouse locations and logistics capabilities are not publicly disclosed. However, the bank's involvement in pharmaceutical imports suggests a distribution network that ensures the efficient delivery of imported medicines to various regions within Nepal. This network likely includes partnerships with local distributors, pharmacies, and healthcare institutions to facilitate the widespread availability of imported pharmaceutical products.

3Industry Role

In Nepal's pharmaceutical supply chain, Everest Bank Ltd functions as an importer of finished pharmaceutical formulations. By sourcing these products from Indian manufacturers, the bank plays a role in supplementing the domestic pharmaceutical market, particularly in therapeutic areas where local production may be limited. This importation strategy contributes to the diversification of available pharmaceutical products, potentially enhancing competition and improving access to a broader range of medicines for the Nepalese population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Everest Bank Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Everest Bank Ltd's pharmaceutical import portfolio is highly concentrated, with the top five products accounting for 100% of the total import value. This indicates a strategic focus on specific high-demand products, such as Ayurvedic and herbal products, which constitute 96.3% of the imports, and advanced oncology treatments, representing 3.7%. The significant reliance on a limited number of products suggests a targeted approach to meet specific market needs. However, this concentration also exposes the bank to risks associated with supply chain disruptions or regulatory changes affecting these particular products.

2Supply Chain Resilience

The resilience of Everest Bank Ltd's supply chain is influenced by its reliance on a select group of Indian suppliers, including EMAMI LIMITED, ZYDUS WELLNESS PRODUCTS LIMITED, and NATCO PHARMA LIMITED. This concentrated supplier base may pose challenges in terms of supply chain stability, especially if any of these suppliers face operational issues or regulatory hurdles. Diversifying the supplier base and establishing relationships with additional manufacturers could enhance supply chain resilience and mitigate potential risks.

3Strategic Implications

Importing Pharmaceuticals into Nepal — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nepal

1Regulatory Authority & Framework

The Department of Drug Administration (DDA), operating under Nepal's Ministry of Health and Population, is the primary regulatory authority overseeing the pharmaceutical sector. Established in 1979, the DDA is responsible for regulating the production, marketing, import, export, storage, supply, sale, and distribution of medicines and health technologies. The legal framework governing pharmaceuticals in Nepal includes the Drug Act 2035 (1978), Drug Registration Regulation 2038 (1981), and Drug Standard Regulation 2043 (1986), among others. These regulations ensure the safety, efficacy, and quality of pharmaceutical products in the country.

2Import Licensing & GMP

Importers of pharmaceutical products into Nepal must obtain an import license from the DDA. This process involves submitting an application along with necessary documentation, including a Good Manufacturing Practice (GMP) certificate from the exporting country. The DDA recognizes GMP certifications from reputable authorities such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, importers must ensure that the products comply with Nepal's quality standards and obtain marketing authorization before distribution.

Quality & Labeling

Everest Bank Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Everest Bank Ltd's import strategy focuses on Ayurvedic and herbal products, as well as advanced oncology treatments. This focus aligns with the growing demand for alternative medicine options and the need for specialized cancer therapies in Nepal. The bank's imports in these categories suggest a strategic approach to address specific health concerns prevalent in the country, catering to a segment of the population seeking traditional and advanced treatment options.

2Sourcing Profile

The bank's sourcing strategy emphasizes finished pharmaceutical formulations, particularly in the Ayurvedic and advanced oncology segments. By importing these products from India, Everest Bank Ltd leverages the proximity and established pharmaceutical manufacturing capabilities of Indian suppliers. This approach allows the bank to offer a diverse range of products to the Nepalese market, meeting both traditional and modern healthcare needs.

3Market Positioning

Through its importation of specific pharmaceutical products, Everest Bank Ltd serves a niche segment of the Nepalese market, focusing on consumers seeking Ayurvedic and advanced oncology treatments. This positioning enables the bank to cater to the needs of patients and healthcare providers requiring these specialized products, contributing to the overall diversity and availability of pharmaceutical options in Nepal.

Seller's Guide — How to Become a Supplier to Everest Bank Ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Everest Bank Ltd, particularly those specializing in Ayurvedic and advanced oncology products. By aligning with the bank's import focus, Indian exporters can access the Nepalese market, benefiting from the bank's established distribution channels and market insights. However, potential suppliers should be prepared to meet Nepal's regulatory requirements, including obtaining GMP certifications recognized by the DDA and adhering to labeling and quality standards.

2Requirements & Qualifications

Indian exporters aiming to supply Everest Bank Ltd must ensure their products are manufactured in facilities with GMP certifications recognized by the DDA, such as those from WHO or PIC/S. Additionally, products must comply with Nepal's quality standards, including batch testing and stability requirements. Labeling must be in the Nepali language, providing comprehensive product information. Exporters should also be prepared to navigate Nepal's import licensing procedures and obtain the necessary marketing authorizations.

3How to Approach

Frequently Asked Questions — Everest Bank Ltd

What products does Everest Bank Ltd import from India?

Everest Bank Ltd imports 2 pharmaceutical products across 2 categories. Top imports: Ayurvedic ($507.5K), Carfilzomib ($19.5K).

Who supplies pharmaceuticals to Everest Bank Ltd from India?

Everest Bank Ltd sources from 7 verified Indian suppliers. The primary supplier is Emami Limited (60.1% of imports, $1.9M).

What is Everest Bank Ltd's total pharmaceutical import value?

Everest Bank Ltd's total pharmaceutical import value from India is $526.9K, based on 85 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Everest Bank Ltd focus on?

Everest Bank Ltd imports across 2 categories. The largest: Ayurvedic & Herbal Products (96.3%), Advanced Oncology (3.7%).

Get Full Everest Bank Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.